IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line
- PMID: 30338032
- PMCID: PMC6188063
- DOI: 10.18632/oncotarget.26049
IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line
Abstract
Insulin-like growth factors (IGFs) have been shown to induce proliferation of many types of cells. Insulin receptor substrates (IRSs) are major targets of IGF-I receptor (IGF-IR) tyrosine kinase activated by IGFs, and are known to play important roles in the activation of downstream signaling pathways, such as the Erk1/2 pathway. Dysregulation of IGF signaling represents a central tumor promoting principle in human carcinogenesis. Prostate carcinoma is highly dependent on the IGF/IGF-IR/IRS axis. Here we identified the deubiquitinase, ubiquitin specific peptidase 9X (USP9X) as a novel binding partner of IRS-2. In a human prostate carcinoma cell line, small interfering RNA (siRNA)-mediated knockdown of USP9X reduced IGF-IR as well as IRS-2 protein levels and increased their ubiquitination. Knockdown of USP9X suppressed basal activation of the Erk1/2 pathway, which was significantly restored by exogenous expression of IRS-2 but not by IGF-IR, suggesting that the stabilization of IRS-2 by USP9X is critical for basal Erk1/2 activation. Finally, we measured anchorage-independent cell growth, a characteristic cancer feature, by soft-agar colony formation assay. Knockdown of USP9X significantly reduced anchorage-independent cell growth of prostate carcinoma cell line. Taken all together, our findings indicate that USP9X is required for the promotion of prostate cancer growth by maintaining the activation of the Erk1/2 pathway through IRS-2 stabilization.
Keywords: IGF-I; IRS-2; USP9X; prostate cancer; ubiquitin.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare no conflicts of interest associated with this manuscript.
Figures





Similar articles
-
The IGF-Independent Role of IRS-2 in the Secretion of MMP-9 Enhances the Growth of Prostate Carcinoma Cell Line PC3.Int J Mol Sci. 2023 Oct 11;24(20):15065. doi: 10.3390/ijms242015065. Int J Mol Sci. 2023. PMID: 37894751 Free PMC article.
-
Insulin/insulin-like growth factor (IGF) stimulation abrogates an association between a deubiquitinating enzyme USP7 and insulin receptor substrates (IRSs) followed by proteasomal degradation of IRSs.Biochem Biophys Res Commun. 2012 Jun 22;423(1):122-7. doi: 10.1016/j.bbrc.2012.05.093. Epub 2012 May 23. Biochem Biophys Res Commun. 2012. PMID: 22634009
-
Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.Clin Chim Acta. 2010 Feb;411(3-4):172-8. doi: 10.1016/j.cca.2009.10.023. Epub 2009 Nov 11. Clin Chim Acta. 2010. PMID: 19913001
-
The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins.Front Endocrinol (Lausanne). 2015 May 26;6:73. doi: 10.3389/fendo.2015.00073. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26074875 Free PMC article. Review.
-
Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.J Exp Clin Cancer Res. 2004 Sep;23(3):385-94. J Exp Clin Cancer Res. 2004. PMID: 15595626 Review.
Cited by
-
Ubiquitin specific peptidases and prostate cancer.PeerJ. 2023 Feb 16;11:e14799. doi: 10.7717/peerj.14799. eCollection 2023. PeerJ. 2023. PMID: 36811009 Free PMC article. Review.
-
The role of ubiquitination and deubiquitination in urological tumours.Front Pharmacol. 2025 Jul 23;16:1532878. doi: 10.3389/fphar.2025.1532878. eCollection 2025. Front Pharmacol. 2025. PMID: 40771930 Free PMC article. Review.
-
Advances in Targeting Cancer-Associated Genes by Designed siRNA in Prostate Cancer.Cancers (Basel). 2020 Dec 3;12(12):3619. doi: 10.3390/cancers12123619. Cancers (Basel). 2020. PMID: 33287240 Free PMC article. Review.
-
The IGF-Independent Role of IRS-2 in the Secretion of MMP-9 Enhances the Growth of Prostate Carcinoma Cell Line PC3.Int J Mol Sci. 2023 Oct 11;24(20):15065. doi: 10.3390/ijms242015065. Int J Mol Sci. 2023. PMID: 37894751 Free PMC article.
-
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy.Cancers (Basel). 2023 Apr 26;15(9):2496. doi: 10.3390/cancers15092496. Cancers (Basel). 2023. PMID: 37173959 Free PMC article.
References
-
- Heidegger I, Kern J, Ofer P, Klocker H, Massoner P. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis. Oncotarget. 2014;5:2723–35. https://doi.org/10.18632/oncotarget.1884 - DOI - PMC - PubMed
-
- Heidegger I, Ofer P, Doppler W, Rotter V, Klocker H, Massoner P. Diverse functions of IGF / insulin signaling in malignant and noncancerous prostate cells : proliferation in cancer cells and differentiation in noncancerous cells. Endocrinology. 2012;153:4633–43. doi: 10.1210/en.2012-1348. - DOI - PubMed
-
- Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, Zhang X, Divisova J, Britton OL, Mohsin S, Allred DC, Hadsell DL, Lee AV. Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol. 2006;26:9302–14. doi: 10.1128/MCB.00260-06. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous